相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。FGFR2 Gene Amplification in Gastric Cancer Predicts Sensitivity to the Selective FGFR Inhibitor AZD4547
Liang Xie et al.
CLINICAL CANCER RESEARCH (2013)
Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer
Fabrice Andre et al.
CLINICAL CANCER RESEARCH (2013)
Determining the profiles and parameters for gene amplification testing of growth factor receptors in lung cancer
Eva Pros et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Fibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung Cancer
Hye Ryun Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Frequency of Fibroblast Growth Factor Receptor 1 gene amplification in oral tongue squamous cell carcinomas and associations with clinical features and patient outcome
Richard J. Young et al.
ORAL ONCOLOGY (2013)
FGFR2 gene amplification and clinicopathological features in gastric cancer
K. Matsumoto et al.
BRITISH JOURNAL OF CANCER (2012)
AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family
Paul R. Gavine et al.
CANCER RESEARCH (2012)
Translating the Therapeutic Potential of AZD4547 in FGFR1-Amplified Non-Small Cell Lung Cancer through the Use of Patient-Derived Tumor Xenograft Models
Jingchuan Zhang et al.
CLINICAL CANCER RESEARCH (2012)
A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets
Niantao Deng et al.
GUT (2012)
Fibroblast growth factor receptor 2 gene amplification status and its clinicopathologic significance in gastric carcinoma
Eun-Jung Jung et al.
HUMAN PATHOLOGY (2012)
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma
Eleonora Brunello et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
FGFR1 Amplification in Squamous Cell Carcinoma of The Lung
Rebecca S. Heist et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer
Hans-Ulrich Schildhaus et al.
MODERN PATHOLOGY (2012)
FGFR1 expression and gene copy numbers in human lung cancer
Lukas H. Kohler et al.
VIRCHOWS ARCHIV (2012)
FGFR1 is amplified during the progression of in situ to invasive breast carcinoma
Min Hye Jang et al.
BREAST CANCER RESEARCH (2012)
Molecular profiles of EGFR, K-ras, c-met, and FGFR in pulmonary pleomorphic carcinoma, a rare lung malignancy
Soohyeon Lee et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase
Vito Guagnano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer
Amit Dutt et al.
PLOS ONE (2011)
FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
Nicholas Turner et al.
CANCER RESEARCH (2010)
AZD8931, an Equipotent, Reversible Inhibitor of Signaling by Epidermal Growth Factor Receptor, ERBB2 (HER2), and ERBB3: A Unique Agent for Simultaneous ERBB Receptor Blockade in Cancer
D. Mark Hickinson et al.
CLINICAL CANCER RESEARCH (2010)
Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
N. Turner et al.
ONCOGENE (2010)
Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer
Jonathan Weiss et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Fibroblast growth factor signalling: from development to cancer
Nicholas Turner et al.
NATURE REVIEWS CANCER (2010)
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati et al.
ANNALS OF INTERNAL MEDICINE (2009)
Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor I as a prognostic marker for advanced-stage serous ovarian adenocarcinomas
Michael J. Birrer et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey
John P. A. Ioannidis et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2007)
Recurrent FGFR 1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC)
Kolja Freier et al.
ORAL ONCOLOGY (2007)
FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis
Somaia Elbauomy Elsheikh et al.
BREAST CANCER RESEARCH (2007)
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
Koei Chin et al.
CANCER CELL (2006)
分享论文
